MEDICRIME anti-counterfeiting convention adopted
This article was originally published in RAJ Devices
Discussions are under way concerning the date of the opening for signature of the MEDICRIME convention, the first international criminal law instrument that criminalises the counterfeiting of medicines and medical devices and also the manufacture and supply of medical products that are unauthorised or do not comply with security requirements1-3.
You may also be interested in...
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months.
BMS should find out mid-2020 whether its new MS drug will be approved in the EU.